These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7533857)

  • 1. Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.
    Baier G; Baier-Bitterlich G; Looney DJ; Altman A
    J Virol; 1995 Apr; 69(4):2357-65. PubMed ID: 7533857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High affinity mouse-human chimeric Fab against hepatitis B surface antigen.
    Bose B; Khanna N; Acharya SK; Sinha S
    World J Gastroenterol; 2005 Dec; 11(48):7569-78. PubMed ID: 16437680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troybodies and pepbodies.
    Lunde E; Lauvrak V; Rasmussen IB; Schjetne KW; Thompson KM; Michaelsen TE; Brekke OH; Sollid LM; Bogen B; Sandlie I
    Biochem Soc Trans; 2002 Aug; 30(4):500-6. PubMed ID: 12196123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
    Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
    Löffler D; Welschof M; Goldmann SF; Wölpl A
    Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
    Liang M; Chu YK; Schmaljohn C
    Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
    Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
    Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of class II major histocompatibility complex molecules on antigen-presenting cells by antibody fragments.
    Vidović D; Falcioni F; Siklodi B; Belunis CJ; Bolin DR; Ito K; Nagy ZA
    Eur J Immunol; 1995 Dec; 25(12):3349-55. PubMed ID: 8566022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.
    Newton DW; Dohlsten M; Lando PA; Kalland T; Olsson C; Kotb M
    Int J Mol Med; 1998 Jan; 1(1):157-62. PubMed ID: 9852214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition by class II alloreactive T cells of processed determinants from human serum proteins.
    Panina-Bordignon P; Corradin G; Roosnek E; Sette A; Lanzavecchia A
    Science; 1991 Jun; 252(5012):1548-50. PubMed ID: 1710827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
    Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
    J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.
    Samuelsson A; Chiodi F; Ohman P; Putkonen P; Norrby E; Persson MA
    Virology; 1995 Mar; 207(2):495-502. PubMed ID: 7886953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
    Dahan R; Tabul M; Chou YK; Meza-Romero R; Andrew S; Ferro AJ; Burrows GG; Offner H; Vandenbark AA; Reiter Y
    Eur J Immunol; 2011 May; 41(5):1465-79. PubMed ID: 21469129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
    Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
    Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chimeric mouse-human anti-CD4 Fab 13B8.2 expressed in baculovirus inhibits both antigen presentation and HIV-1 promoter activation.
    Bès C; Cerutti M; Briant-Longuet L; Bresson D; Peraldi-Roux S; Pugnière M; Mani JC; Pau B; Devaux C; Granier C; Devauchelle G; Chardès T
    Hum Antibodies; 2001; 10(2):67-76. PubMed ID: 11673661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
    Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
    Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting antigens to an invariant epitope of the MHC Class II DR molecule potentiates the immune response to subunit vaccines.
    Gil F; Pérez-Filgueira M; Barderas MG; Pastor-Vargas C; Alonso C; Vivanco F; Escribano JM
    Virus Res; 2011 Jan; 155(1):55-60. PubMed ID: 20817054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.